Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 5921 - 5928 of 12089 results

These Statistics Keep Health Care Execs Up At Night
July 31, 2018| Blog| Viewpoint

Who Can Decide Whether 'Class Arbitration' Is Authorized?
July 30, 2018| News

Potential Changes to PAMA Reporting in Medicare Physician Fee Schedule Rule
July 30, 2018| Blog| Viewpoint

ML Strategies Weekly Health Care Preview – July 30, 2018
July 30, 2018| Blog| Viewpoint

Question of Authority at Heart of Labor Dept. Health Rule Case
July 30, 2018| News

New California Law Extends Defamation Privilege to Communications Related to Sexual Harassment Claims and Investigations
July 27, 2018| Blog| Viewpoint

What You Need To Know About Patent Litigation In Germany
July 27, 2018| News

California Clarifies its Salary History Ban
July 27, 2018| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
